You usually make a lot of sense but this post is being deceptive. A colonoscopy is needed to determine the size, complexity and severity of a tumour. This test was never spruiked as a replacement for a colonoscopy but a replacement for FIT, which it does. This test is an early warning system only and that's what it always was. The fact the team can't get their act together and get it to market is another matter. It is poor form to make false equivalence between colostat and a colonoscopy.
Ann: Platform Expansion - Lung Cancer Diagnostic Test Update, page-12
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $27.34M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.5¢ | $28.53K | 259.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 42630 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 38349 | 2 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |